Kiyohara H, Hanamura T, Sagara Y, Miyashita M, et al. Real-world outcomes of everolimus-based therapy after CDK4/6 inhibitor therapy in ER-positive/HER2-negative metastatic breast cancer: a multicenter registry-based study. Breast Cancer 2026 Nov 10. doi: 10.1007/s12282-026-01931.
PMID: 43007633